(Q31159589)

29 June 2017

title

Protein studies in dysferlinopathy patients using llama-derived antibody fragments selected by phage display (English)

1 reference

29 June 2017

0 references

1 reference

1 reference

13

Johan den Dunnen

0 references

Andreas Roussis

object named as

Andreas Roussis

3

0 references

Silvère M van der Maarel

object named as

Silvère M van der Maarel

14

0 references

Rune Frants

10

object named as

Rune R Frants

1 reference

29 June 2017

Yanchao Huang

1

1 reference

29 June 2017

Peter Verheesen

2

1 reference

29 June 2017

Wendy Frankhuizen

4

1 reference

29 June 2017

Ieke Ginjaar

5

1 reference

29 June 2017

Faye Haldane

6

1 reference

29 June 2017

Steve Laval

7

1 reference

29 June 2017

Louise V B Anderson

8

1 reference

29 June 2017

Theo Verrips

9

1 reference

29 June 2017

Hans de Haard

11

1 reference

29 June 2017

Kate Bushby

12

1 reference

29 June 2017

publication date

1 June 2005

1 reference

European Journal of Human Genetics

29 June 2017

published in

1 reference

29 June 2017

volume

13

1 reference

29 June 2017

issue

6

1 reference

29 June 2017

page(s)

721-730

1 reference

Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy

29 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Myoferlin, a candidate gene and potential modifier of muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Defective membrane repair in dysferlin-deficient muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Caveolin-3 in muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Pentamerization of single-domain antibodies from phage libraries: a novel strategy for the rapid generation of high-avidity antibody reagents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Selection by phage display of llama conventional V(H) fragments with heavy chain antibody V(H)H properties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Isolation of antigen specific llama VHH antibody fragments and their high level secretion by Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Llama-derived phage display antibodies in the dissection of the human disease oculopharyngeal muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Towards proteome-wide production of monoclonal antibody by phage display

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Determination of active single chain antibody concentrations in crude periplasmic fractions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Single section Western blot: Improving the molecular diagnosis of the muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Comparison of llama VH sequences from conventional and heavy chain antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Llama heavy-chain V regions consist of at least four distinct subfamilies revealing novel sequence features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Variable reduction of caveolin-3 in patients with LGMD2B/MM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Antibodies in haystacks: how selection strategy influences the outcome of selection from molecular diversity libraries

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

The "rescue" of dystrophin synthesis in boys with Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201414

7 January 2021

Identifiers

DOI

10.1038/SJ.EJHG.5201414

1 reference

Dimensions Publication ID

29 June 2017

1004324983

0 references

1 reference